Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Completion Rate
    0%(0/1)
    Active Trials
    1(50%)
    Terminated
    1(50%)

    Phase Distribution

    Phase 2
    1
    50%
    Phase 2/3
    1
    50%

    Phase Distribution

    0

    Early Stage

    2

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 2Efficacy & side effects
    1(50.0%)
    Phase 2/3Combined phases
    1(50.0%)

    Highest Phase Reached

    Phase 2/3

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Terminated(1)

    Detailed Status

    Recruiting1
    Terminated1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    0.0%
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 21 (50.0%)
    Phase 2/31 (50.0%)

    Trials by Status

    recruiting150%
    terminated150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    recruitingphase_2_3

    Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis

    NCT06488625
    terminatedphase_2

    A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

    NCT00457951

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT06488625Phase 2/3

    Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis

    Recruiting
    NCT00457951Phase 2

    A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

    Terminated

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2